|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn947837555 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
151207s2016 nyua ob 001 0 eng |
| 010 |
|
|
|a 2020677192
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d N$T
|d OCLCF
|d YDX
|d SNK
|d DKU
|d AUW
|d MHW
|d BTN
|d IGB
|d D6H
|d VTS
|d AGLDB
|d AU@
|d G3B
|d S8J
|d S9I
|d STF
|d VLY
|d OCLCO
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 961409476
|a 1058655876
|
| 020 |
|
|
|a 9781634844178
|q (ebook)
|
| 020 |
|
|
|a 1634844173
|
| 020 |
|
|
|z 9781634844024
|q (hardcover)
|
| 020 |
|
|
|z 1634844025
|
| 029 |
1 |
|
|a AU@
|b 000062420250
|
| 035 |
|
|
|a (OCoLC)947837555
|z (OCoLC)961409476
|z (OCoLC)1058655876
|
| 050 |
0 |
0 |
|a RC280.L9
|
| 060 |
|
4 |
|a QZ 350
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.99/446
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Diffuse large B-cell lymphoma (DLBCL) :
|b symptoms, treatment and prognosis /
|c Haipeng Shao, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical/Nova Science Publishers, Inc.,
|c [2016]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 490 |
1 |
|
|a Cancer etiology, diagnosis and treatments
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on print version record and data provided by publisher.
|
| 505 |
0 |
|
|a DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) SYMPTOMS, TREATMENT AND PROGNOSIS ; DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) SYMPTOMS, TREATMENT AND PROGNOSIS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 Pathologic Diagnosis and Prognostic Markers of Diffuse Large B-Cell Lymphoma; Abstract; Introduction; Epidemiology and Clinical Features; Morphologic and Immunophenotypic Features; Differential Diagnosis; Genetic and Molecular Features; Prognostic Markers; Morphologic Subtypes and Other Entities; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
|
| 505 |
8 |
|
|a Primary DLBCL of the Central Nervous SystemPrimary Cutaneous DLBCL, Leg Type; EBV-Positive DLBCL of the Elderly; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Intravascular Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation; Lymphomatoid Granulomatosis; ALK-Positive Large B-Cell Lymphoma; Plasmablastic Lymphoma; Diffuse Large B-Cell Lymphoma with IG/IRF4 Translocation; Large B-Cell Lymphoma Arising in HHV8-Associated Multicentric Castleman Disease; Primary Effusion Lymphoma
|
| 505 |
8 |
|
|a B-Cell Lymphoma, Unclassifiable, with Features Intermediate between DLBCL and Classical Hodgkin LymphomaB-Cell Lymphoma, Unclassifiable, with Features Intermediate between DLBCL and Burkitt Lymphoma; References; Chapter 2 Diffuse Large B-Cell Lymphoma: Diagnosis, Treatment and Prognosis; Abstract; Introduction; Clinical Presentation of DLBCL; Prognosis of DLBCL; Pathologic Characteristics and Classification of DLBCL; DLBCL, Not Otherwise Specified (NOS); Primary Mediastinal Large B-Cell Lymphoma (PMBCL); T-Cell/Histiocyte-Rich Large B-Cell Lymphoma; EBV-Positive DLBCL
|
| 505 |
8 |
|
|a DLBCL in Specific Anatomic SitesDLBCL with Plasma Cell Immunophenotype; B-Cell Lymphoma, Unclassifiable, with Features Intermediate between DLBCL and Burkitt Lymphoma; B-Cell Lymphoma, Unclassifiable, with Features Intermediate between DLBCL and Hodgkin Lymphoma; Treatment of DLBCL; Current Standard of Care: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP); Treatment of Older Adults; Treatment of Patients with Cardiac Dysfunction; HIV-Associated Lymphomas; Primary Mediastinal Large B-Cell Lymphoma; Relapsed/Refractory DLBCL
|
| 505 |
8 |
|
|a Future Directions in the Treatment of DLBCLTargeted Therapies for Surface Markers in DLBCL; Targeted Therapies for GCB-Type DLBCL; Targeted therapies for ABC-Type DLBCL; Chimeric Antigen Receptor T (CAR T)-Cell Therapy; Conclusion; References; Chapter 3 The Evolving Role of Radiation Therapy in the Management of Diffuse Large B-Cell Lymphoma; Abstract; Introduction; The Era of Chop; Prospective Trials; Retrospective Studies; R-CHOP Studies; Advanced Stage; Prospective Evaluation in the Era of R-CHOP; Radiation Techniques; Risk-Adapted Treatment Selection; Conclusion; References
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Lymphomas.
|
| 650 |
|
2 |
|a Lymphoma, Large B-Cell, Diffuse
|
| 650 |
|
2 |
|a Lymphoma
|
| 650 |
|
6 |
|a Lymphome.
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a Lymphomas
|2 fast
|
| 700 |
1 |
|
|a Shao, Haipeng,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Diffuse large B-cell lymphoma (DLBCL)
|d New York : Nova Biomedical, [2016]
|z 9781634844024 (hardcover)
|w (DLC) 2015959363
|
| 830 |
|
0 |
|a Cancer etiology, diagnosis, and treatments.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1226141
|z Texto completo
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 12759194
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1226141
|
| 994 |
|
|
|a 92
|b IZTAP
|
